Text Size

Prevalence of Sexually Transmitted Infections (STIs) in HIV-infected Patients (CTNG)

This study has been completed.
Sponsor:
Collaborators:
Pfizer
Merck
Information provided by:
University Hospital Inselspital, Berne
ClinicalTrials.gov Identifier:
NCT00973466
First received: September 4, 2009
Last updated: January 12, 2011
Last verified: January 2011
History of Changes
  Purpose

There has been an increase in incidence in sexually transmitted infections in HIV infected patients in the last years. In this study the investigators will prospectively evaluate the prevalence of symptomatic and asymptomatic infections with N. gonorrhea and Ch. trachomatis as well as the seroprevalence of Herpes simplex Type 2 infection in HIV-infected patients attending the clinic for infectious diseases at the Berne University Hospital. In addition, participants will be asked to fill out a questionnaire on sexual behaviour and sexual health.

Study hypothesis: STI prevalence is high in certain risk-groups to justify screening in regular intervals.


Condition
HIV Infections
Neisseria Gonorrhoeae
Chlamydia Trachomatis
Herpes Simplex

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Prevalence of Asymptomatic and Symptomatic Infection of N. Gonorrheae and C. Trachomatis and Seroprevalence of HSV Typ 2 and Sexual Health Seeking Behaviour in People With HIV Infection in Bern

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by University Hospital Inselspital, Berne:

Primary Outcome Measures:
  • Prevalence of infection with C.trachomatis, N. gonorrhea and Seroprevalence of HSV 2 infection [ Time Frame: 6 months ] [ Designated as safety issue: No ]

Estimated Enrollment: 300
Study Start Date: May 2009
Study Completion Date: June 2010
Primary Completion Date: May 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts
HIV-infection
All HIV-infected patients attending the Clinic for Infectious Diseases at Berne university hospital, having been sexually active during the past 12 months and having given written informed consent

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

All consecutive HIV-infected patients attending the Clinic for Infectious Diseases at Bern University Hospital will be asked to participate in the study if they were sexually active during the last 12 months

Criteria

Inclusion Criteria:

  • HIV-infection
  • Attending the Clinic for Infectious Diseases from May 09 to November 09
  • Sexually active during the last 12 months
  • Written informed consent

Exclusion Criteria:

  • None
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00973466

Locations
Switzerland
Clinic for Infectious Diseases, Berne University Hospital
Bern, Switzerland, 3010
Sponsors and Collaborators
University Hospital Inselspital, Berne
Pfizer
Merck
Investigators
Principal Investigator: Hansjakob Furrer, MD University Hospital Berne
  More Information

No publications provided

Responsible Party: Hansjakob Furrer, Leitender Arzt, University Hospital Inselspital, Berne
ClinicalTrials.gov Identifier: NCT00973466     History of Changes
Other Study ID Numbers: KEK26/09
Study First Received: September 4, 2009
Last Updated: January 12, 2011
Health Authority: Switzerland: Ethikkommission

Keywords provided by University Hospital Inselspital, Berne:
HIV-infection
Neisseria gonorrhea
Chlamydia trachomatis
Herpes simplex virus
prevalence

Additional relevant MeSH terms:
HIV Infections
Acquired Immunodeficiency Syndrome
Chlamydia Infections
Gonorrhea
Herpes Simplex
Sexually Transmitted Diseases
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Virus Diseases
Sexually Transmitted Diseases, Viral
Immunologic Deficiency Syndromes
Immune System Diseases
Slow Virus Diseases
 Chlamydiaceae Infections
Gram-Negative Bacterial Infections
Bacterial Infections
Sexually Transmitted Diseases, Bacterial
Infection
Genital Diseases, Male
Genital Diseases, Female
Neisseriaceae Infections
Herpesviridae Infections
DNA Virus Infections
Skin Diseases, Viral
Skin Diseases, Infectious
Skin Diseases

ClinicalTrials.gov processed this record on March 10, 2013